REFERENCIAS

1. Abe T., Yamaya Y., Wada Y., Suzuki M (1983) Pituitary-ovarian relationships in women approaching the menopause. Maturitas 5: 31-37.

2.Aedo AR., Landgren BM., Diezfalusy E (1990) Pharmacokinetics and biotransformation of orally administored oestrone sulphate and oestradiol valerate in postmenopausal women. Maturitas 12: 333-343.

3. Ballinger CB., Browning MC,, Smith AH (1987) Hormone profiles and psychological symptoms in perimenopausal women. Maturitas 9.235-251.

4. Bohler CS., Greenblatt RB (1974) The pathophysiology of the hot flush. In the Menopausal Syndrome. Medicom Press, New York pp. 29-38

5. Bonithon-Kopp C., Searabin P., Dame B., Malmejae A., Guízc L (1990) Menopause-related changos in lipoproteina and somo other cardiovascular risk factom. Int. J. Epiderniol. 19:42-48.

6.Carrillo C., González del Riego M., Gonzáles GF (1991) Menopausia post-ooforectomía: Correlato clínico endocrinológico. XII reunión de la Asociación Latinoamericana de Investigaciones en Reproducción Humana, Caracas. Abst. 31

7. Casper RF., Yen SSC., Wilker M (1979) Menopausal flushes and the pulsatile release of luteinizing hormone. Science 205: 823.

8. Cauley JA., Gutai JP., Kuller LH., LeDonno D., PoweU JG (1989) The epidemiology of serum sex hormones in post-menopausal women. Am. J. Epidemiol. 129:1120-1131.

9. Casper RF., Alapin-Rubillovitz S (1985) Progestins increase endogenous opioid peptide activity in postmenopausal women. J Clin Endocrinol Metab 60: 34

10. CasperRF., Yen SSC (1985) Neuroendocrinology of menopausal flushes: an hypothegis of flush machanism. Clin Endocrinol (Oxf) 22:293

11. Chakravarti F, Collina WP, Newton JR, Oram BH, Studd JW. Endocrine changes and symptomatology after oophorectomy in premonopausal women. Brit. J. Obst. Gynecol 1977; 84:769-775

12. Coppen A., Tumer P., RowacU AR., Padagjharn C (1976) S-hydroxytryptamine in the whole blood of patients with depressivo ilIness. Postgrad. Med. 52: 156.

13. de Aloysio D., Villecco AS., Fabiani AG., Mauloni M., Altieri P., Miliffl L., Bottiglioni F (1988) Body masa indox distribution in climateric women. Maturitas 9:359-366.

14. de Aloysio D., Fabiani AG., Mauloni-M., Bottiglioni F (1989) Analysis of the climateric syndrome. Maturitas 11: 43-53

15. De Simono DP., Steveno J., Edwards J., Shary J., Gordon L., Bell NH (1989) Influence of body habitua and roce on bono mineral density of the midradius, hip, and spine in aging women. J. Bono Min. Res. 4: 827-830

16.Ehrenkmnz JR. Effect of sex steroids on serotonin uptake in blood plateleta. Acta Endocrinol (Cophenh). 1976; 83:420-428

17. Farish E., Fletcher CD., Hart DM., Smith MI, (1990) Effecta of bilateral oophorectorny on lipoprotein metabolism. Br. J. Obstet. Gynaecol. 97:78-82

18. Ferin M., van Vugt D., Wardlaw S (1984) The hypothalamie control of the menstrual cycle and tho rolo of endogenous opiod peptides. Recent Prog. Horm Res 40: 441

19. Gceraerto F, Schimpfessel L, Croakaert R. A simple routino method to preserve and determine blood serotonin. Experientia. 1974; 30:837-838

20. Gonzáles GF. (1980) Blood levels of 5?hydroxytryptamino in human beingo under several physiological situations. Life Sci; 27: 647-650

21.Gonzáles GF (1983) Endocrinología en las grandes alturas. Rey ANBIOP (Perú) 2:9-66

22.Gonzáles GF (1986) Neuroendocrinología. Rey AN1310P (Lima) 3 (1) 44-70

23. Gonzáles GF (1986a) Neuroendocrinología. II parte. Rev AN1310P (Urna) 3(2): 68-82

24. Gonzáles GF (1988) Fisiopatología del eje hipotétamo-hipofisiario. Diagnóstico 21: 176-180

25. Gonzáles GF (1992) Fisiología y Patología de la Reproducción en las grandes alturas. Acta Andina: 1: 113.

26. Gonzáles GF (1993) Menopausia en la altura. En. Reproducción Humana en la Altura. GF. Gonzáles (edo). Ediciones IIA, Lima. pp. 57-72.

27. Gonzáles GF., Mendoza L., Ruiz J., Torrejon J (1982) A demonstration that S-hydroxytryptamine administered peripherally can affect sexual behavior in male rats. Life Sci. 31: 2775.

28. Gonzáles GF; Carrillo CE., Villena A., Alarcón 1 (1993) Factores biomédicos que determinan la fertilidad en la altura. Acta Andina 2: 141-160.

29. Gonzáles GF., y Carrillo C (1993) Blood serotonin levels ins post-menopause women: Effects of ago and serum estradiol levels. Maturitas 17:23-29

30. Gordon T., Kannel WB., Hjortland MC., McNamara PM (1978) Menopause and coronary heart disease: The Framingham Study. Ann Intern Med 89:157-161

31. Gosden RG (1987) Follicular status at the menopause. Human Reprod. 2: 617-621

32. Guicheney P, Leger D, Barrat J, Trevoux R, De Ligniere B, Roques P, Gamier JP, Boyer P, Grenier J, Dreux C. (1988) Platelet serotonin content and plasma tryptophan in peri-and postmenopausal women: variations with plasma oestrogen levels and depresive symptoms. Eur J Clin Invest. 19: 297-304

33.Guicheney P, Marcel D. (1984) Decrease platelet serotonin content in ovariectomized female rats. Endocrinology; 114: 2412-2414

34.Haas S., Walsh B., Evans S., Krache M., Rovnikar V., Schiff 1 (1988) The effect of trazisdermal estradiol on hormone and metabolic dynamics over a six week period. Obstet Gynecol 71:671.

35.INEI (1992) Encuesta demográfica y de Salud Familiar 1991/1992. Lima, 253 pp.

36.Jensen,J., Nilas L., Christiansen C (1990) Influence of menopause on serum lipids and lipoproteins. Maturitas 12:321-331

37.Judd HL (1976) Hormonal dynamics associated with the menopause. Clin Obst Gynecol. 19:775

38.Koplan R., Mann J (1982) Altered platelet serotonin uptake kinetics in schizoophrenia and depression. Life Sci. 31: 583

39.Koster A (1990) Hormone replacement therapy: use patterns in 51 year old Danish women. Maturitas 12: 345-356

40.Matthows KA., Meilahn E., KuIler LH., KeIsey SF., Caggiula AW., Wing RR (1989) Menopause and risk factors for coronary hean disease. New Engl. J. Med. 321:641-646

50. McKinlay SM, Jeffrey M. The menopausal syndrome. British J. Prev. Soc. Med. 1974; 28:108-115

51.Meldrum DR., Erfik Y., Lu JRH., Judd HL (1981) Objectively recorded hot flushes in patients with pituitary insufficiency. J. Clin Endocrinol. Metab 52:684

52.Metealf MG (1988) The approach of menopause: a New Zeland study, N. Z. Med. J: 101:103-106

53. Miller-Bass K., Adashi E (1990) Current status and future prospects of transdermal estrogen replacement therapy. Fertil. Steril. 53:961-974

54.Mongo C., León-Velarde F., Arregui A (1989) Increasing prevalence of excessive erythrocytosis with ago among healthy high altitude miners. New Engl. J. Medic. 321:1181

55.Musey VC, Collins DC., Musey PI, Martino?Saltzman D, Proedy JRK (1987) Ago related changes in the female hormonal environment during reproductive life. Am J Obst Gynecol 157:312

56. Nilas L., Christiansen C (1989) The pathophysiology of peri-and postmenopausal bone loss. Br. J. Obstet. Gynaecol. 96:580-387

57.Orentreich N., Brind JL., Rizer RL., Vogelman JH (1984) Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59:551

58.Paasonen-MK. Release of 5?hydroxytryptamine from blood platelets. J. Pharm Pharmacol. 1965; 17: 681

59.Pago IH., McCubbin JW (1953) Variable arterial pressure responso to serotonin in laboratory animals and man. Circulat. Res. 1: 354.

60.Peters H., Byskov AG., Grinsted J (1980) Crecimiento folicular en los ovarios fetalos y prepuberales de la mujer y otros primates. En Clínica Endocrinológica: Endocrinología Reproductiva. 6(3). Salvat Ed. pp. 1-18

61.Petroglia F., Segre A., Faechinetti F., Campanini D., Ruspa M., Genazzoni AR (1985) B-endorphin and met-enkephalin peritoneal and ovarian follicular fluids of fertile and post-menopausal women. Fertil. Steril. 44:615

62.Powers MS., Schenkel L., Darley PE y col (1985) Pharmacolcinetics and pharmacodynamics of transdermal dosage forma of 17-11-estradiolcomparison with conventional oral estrogeno used for hormone replacement. Am. J. Obst. Gynecol. 152:1099.

63.Reid RL., Quigley ME., Yen SSC (1983) The disappearance of opioidergic regulation of gonadotropin secretion in post-menopausal women. J. Clin Endocrinol. Metab 57:1107

64.Richardson SJ., Senikas V., Nelson JF (1987) Folicular depletion during the menopausal transition: ovidenco for accelemted loss and ultimate exhaustion. J Clin Endocrinol Metab 65:1231-1237

65.Rozenheg S., Ham H., Bosson D., Poretz A., Robyn C(1990) Age, steroids and bono mineral content. Maturitas 12: 137-143.

66.Schurz B., Wimmer?Greinecker G., Metka M., Heymanck 0., Egarter Ch., Knogler W (1988) B?endorphin levels during the climatoric poriod. Maturitas 10:45

67.Seifer DE., Collins RL (1990) Current concepto of B?endorphin physiology in female reproductivo dysfunction. Fertil Steril 54: 757-771

68. Shideler SE., DeVane GW., Kalm PS., Bonirsehke, K., Lasley EL (1989) Ovarian?Pituitary hormone interactions during the perimenopause. Maturitas 11:331-339.

69. Taelman P., Kaufman JM., Janasena X., Vermeulen, A (1989) Persistence of increased bono resorpfion and possible role of dohydroepiandromerone as a bono metabolism determiant osteoporotic women in late postmenopause. Maturitas ti: 65-73.

70. Tepper R., Neri A., Kaufman H., Schoenfeld A., Ovadia J (1987) Menopausal hot flushes and B?ondorphino. Obstetr. Gynecol. 70: 150

71. Utian VM. The true clinical features of the postmenopause and oophorectomy and their response to oestrogen therapy. South African Med J. 1972; 46: 732-737

72.Vermeulen A (1987) Adrenal androgeno and aging. Edited by AR Genazzani, JHH Thijssen, PK Siiteri. Nueva York, Rayen Preso, p. 207

73.Vormoulen A (1990) Plasma fipid and lipoprotein levelo in obese post-menopausal wornen: effects of a short term low-protein diet and exercise. Maturitas 12:121-126

74.Yen SSC., Taai CC., Naftolin F., Vandorberg G., Ajabar L (1972) Pulsatilo pattema of gonadotropin release in subjects with and without ovarian function. J CU Endocrinol Metab 34:671

75. Zwicke DL., Niazi I., Reeves WC., Wagel SS (1986) Reduced transcutaneous nitroglycerin absorption in blacks. Circulation 74 (suppl 11):543, 1986

76.ZyIstra S., Hopkína A., Erk M., Hreshchyshyn MM., Anbar M (1989) Effect of physical activity on lumbar spine and femoral nock bono densities. Int. J. Sport Med. 10: 181-186.